These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2999581

  • 21. Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells.
    Bonavida B, Wright SC.
    J Clin Immunol; 1986 Jan; 6(1):1-8. PubMed ID: 3958135
    [Abstract] [Full Text] [Related]

  • 22. Effect of altered membrane structure on NK cell-mediated cytotoxicity. III. Decreased susceptibility to natural killer cytotoxic factor (NKCF) and suppression of NKCF release by membrane rigidification.
    Roozemond RC, Mevissen M, Urli DC, Bonavida B.
    J Immunol; 1987 Sep 01; 139(5):1739-46. PubMed ID: 3624869
    [Abstract] [Full Text] [Related]

  • 23. Soluble cytotoxic factors and the mechanism of NK cell mediated cytotoxicity.
    Bonavida B, Wright SC.
    Adv Exp Med Biol; 1982 Sep 01; 146():379-88. PubMed ID: 7102465
    [Abstract] [Full Text] [Related]

  • 24. Lysis of natural killer-sensitive and -resistant tumor cells by natural killer cytotoxic factors (NKCF)-containing liposomes.
    Roozemond RC, Urli DC, Wright SC, Graves SS, Bonavida B.
    Immunobiology; 1987 Dec 01; 176(1-2):35-46. PubMed ID: 3447981
    [Abstract] [Full Text] [Related]

  • 25. Studies on the mechanism of the human natural killer cell lethal hit: evidence for transfer of protease-sensitive structures requisite for target cell lysis.
    Hiserodt JC, Britvan LJ, Targan SR.
    J Immunol; 1983 Dec 01; 131(6):2710-3. PubMed ID: 6358353
    [Abstract] [Full Text] [Related]

  • 26. Relationship between radical production and natural killer cytotoxic factor (NKCF) in canine natural killer (NK) cell-mediated cytotoxicity.
    Nakada Y, Tsukatani Y, Kosaka T, Kuwabara M, Tanaka S, Fujiwara K.
    Vet Immunol Immunopathol; 1997 Mar 01; 55(4):273-82. PubMed ID: 9151399
    [Abstract] [Full Text] [Related]

  • 27. Characterization of natural killer cytotoxic factor (NKCF) from canine NK cells.
    Nakada Y, Soga M, Kosaka T, Tsukatani Y, Miyamori M, Kuwabara M, Tanaka S, Koide F, Fujiwara K.
    Vet Immunol Immunopathol; 1996 Jan 01; 49(4):283-93. PubMed ID: 8677631
    [Abstract] [Full Text] [Related]

  • 28. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
    Bonavida B, Katz J, Hoshino T.
    Cell Immunol; 1986 Oct 01; 102(1):126-35. PubMed ID: 3492275
    [Abstract] [Full Text] [Related]

  • 29. Properties and characterization of a rat spleen cell-derived factor that induces resistance to natural killer cell lysis in YAC lymphoma cells.
    Saxena RK, Saxena QB, Adler WH.
    J Immunol; 1988 Sep 01; 141(5):1782-7. PubMed ID: 2457628
    [Abstract] [Full Text] [Related]

  • 30. Release of natural killer cytotoxic factor in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Trentin L, Agostini C, Chisesi T, Vespignani M, Pizzolo G, Pandolfi F, Ensoli F, Semenzato G.
    Leuk Res; 1989 Sep 01; 13(4):315-22. PubMed ID: 2497276
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Sequential substages of natural killer cell-derived cytolytic factor (NKCF)-mediated cytolysis as defined by glutaraldehyde modulation of the target cell.
    Deem RL, Targan SR.
    J Immunol; 1984 Oct 01; 133(4):1836-40. PubMed ID: 6432901
    [Abstract] [Full Text] [Related]

  • 33. Human natural killer cytotoxic factor (NKCF): role of IFN-alpha.
    Steinhauer EH, Doyle AT, Kadish AS.
    J Immunol; 1985 Jul 01; 135(1):294-9. PubMed ID: 3998466
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes.
    Shanahan F, Niederlehner A, MacDermott RP, Stenson WF, Kane MG, Targan S.
    Immunopharmacology; 1986 Apr 01; 11(2):111-8. PubMed ID: 2872187
    [Abstract] [Full Text] [Related]

  • 36. Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon.
    Steinhauer EH, Doyle AT, Reed J, Kadish AS.
    J Natl Cancer Inst; 1985 Dec 01; 75(6):1017-23. PubMed ID: 2415742
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sera from patients with colon, breast and lung cancer induce resistance to lysis mediated by NK cytotoxic factors (NKCF).
    Marubayashi M, Solana R, Ramirez R, Aranda E, Galan F, Peña J.
    Br J Cancer; 1991 Jun 01; 63(6):893-6. PubMed ID: 1906292
    [Abstract] [Full Text] [Related]

  • 39. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD, Mitsuyasu R, Gottlieb MS, Lebow LT, Bonavida B.
    J Immunol; 1987 Jul 01; 139(1):55-60. PubMed ID: 3584988
    [Abstract] [Full Text] [Related]

  • 40. An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids.
    Kiyohara T, Dennis JW, Boegman RJ, Roder JC.
    J Immunol; 1985 Jul 01; 135(1):659-64. PubMed ID: 3923114
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.